Your browser doesn't support javascript.
loading
Microcurrent-Mediated Modulation of Myofibroblasts for Cardiac Repair and Regeneration.
Bachamanda Somesh, Dipthi; Jürchott, Karsten; Giesel, Thomas; Töllner, Thomas; Prehn, Alexander; Richters, Jan-Peter; Kosevic, Dragana; Eduardo Rame, Jesus; Göttel, Peter; Müller, Johannes.
Afiliación
  • Bachamanda Somesh D; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Jürchott K; BIH Center for Regenerative Therapies, Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health at Charité, Universitätsmedizin Berlin, 13353 Berlin, Germany.
  • Giesel T; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Töllner T; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Prehn A; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Richters JP; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Kosevic D; Dedinje Cardiovascular Institute, Dedinje University Hospital, 11040 Belgrade, Serbia.
  • Eduardo Rame J; Jefferson Heart Institute, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
  • Göttel P; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
  • Müller J; Berlin Heals, 59-61 Knesebeck Str, 10719 Berlin, Germany.
Int J Mol Sci ; 25(6)2024 Mar 13.
Article en En | MEDLINE | ID: mdl-38542242
ABSTRACT
Cardiovascular diseases are a significant cause of illness and death worldwide, often resulting in myofibroblast differentiation, pathological remodeling, and fibrosis, characterized by excessive extracellular matrix protein deposition. Treatment options for cardiac fibrosis that can effectively target myofibroblast activation and ECM deposition are limited, necessitating an unmet need for new therapeutic approaches. In recent years, microcurrent therapy has demonstrated promising therapeutic effects, showcasing its translational potential in cardiac care. This study therefore sought to investigate the effects of microcurrent therapy on cardiac myofibroblasts, aiming to unravel its potential as a treatment for cardiac fibrosis and heart failure. The experimental design involved the differentiation of primary rat cardiac fibroblasts into myofibroblasts. Subsequently, these cells were subjected to microcurrent (MC) treatment at 1 and 2 µA/cm2 DC with and without polarity reversal. We then investigated the impact of microcurrent treatment on myofibroblast cell behavior, including protein and gene expression, by performing various assays and analyses comparing them to untreated myofibroblasts and cardiac fibroblasts. The application of microcurrents resulted in distinct transcriptional signatures and improved cellular processes. Gene expression analysis showed alterations in myofibroblast markers, extracellular matrix components, and pro-inflammatory cytokines. These observations show signs of microcurrent-mediated reversal of myofibroblast phenotype, possibly reducing cardiac fibrosis, and providing insights for cardiac tissue repair.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Miofibroblastos / Cardiomiopatías Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Miofibroblastos / Cardiomiopatías Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza